Navigation Links
New Drug Effective for Low Blood Pressure

Patients with a condition called orthostatic hypotension have problems with sinking blood pressure when standing up from a sitting position.// Current treatments help increase blood pressure when standing but also cause blood pressure to soar when lying down, increasing the risk for stroke. Researchers say that a new drug application could help patients with low blood pressure.

Blood pressure control lessens with age, making orthostatic hypotension especially common in those over age 70. Common causes of the condition include diabetes, autonomic neuropathy, multiple system atrophy, pure autonomic failure, and Parkinson's disease. Drugs used to control blood pressure are often catalysts for orthostatic hypotension.

A recent study reveals that the drug pyridostigmine, also known as Mestinon or Mestinon Timespan, could be the answer. Pyridostigmine has been used for years to treat myasthenia gravis, a neuromuscular disease. The drug works at the level of the autonomic ganglion, which has minimal nerve signaling traffic when lying down. When standing up, however, nerve signaling traffic in the autonomic ganglion increases. Researchers theorized a drug that affects the autonomic ganglion would improve nerve transmission for orthostatic hypotension patients and trigger the reflex that controls blood pressure in all positions.

Researchers studied 58 patients. Patients either received a placebo, pyridostigmine alone, or pyridostigmine in combination with one of two low dosages of midodrine (ProAmatine), a drug known to improve orthostatic hypotension. Researchers measured the effects of the drugs one hour post-treatment. Pyridostigmine significantly improved the patients' standing blood pressure without raising blood pressure lying down. The positive effects of the drug were further improved when combined with low-dose midodrine. Side effects were mild, including some abdominal cramping or the need to use the bathroom more than usual. A follow-up occurred two years after the trial. Information was available on 32 of the patients, and 75 percent reported either good or excellent results from the pyridostigmine treatment. About 25 percent used pyridostigmine alone, and about 33 percent needed a lower dose of another medication. Researchers conclude saying that in the future more study needs to be done in this area .

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
4. Fluoride Found Effective in Osteoporosis
5. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
6. Implantable Contact Lens Found Safe and Effective
7. Effective And Economical Agent For Anthrax
8. Stem Cell Transplants May Be Effective For MS Patients
9. Effective therapy for Huntingtons disease
10. Chemotherapy Effective for Bladder Cancer
11. Drug Effective for Vascular Dementia
Post Your Comments:

(Date:11/25/2015)... , ... November 25, 2015 , ... ... is offering lower prices in an early celebration of the early holiday shopping ... price of $29.95 each (normally $33.95 ea). Black Friday promotional pricing is in ...
(Date:11/24/2015)... ON (PRWEB) , ... November 24, 2015 , ... New ... Williams without a referral for dental implants at her Mississauga, ON practice. ... and experienced in the placement of dental implants. , Missing teeth can lead ...
(Date:11/24/2015)... ... ... In an article published November 12th by Obesity News Today, ... are not eligible for bariatric surgery. The article explains that candidates for weight loss ... pounds overweight, or have a BMI of 35 and over with at least two ...
(Date:11/24/2015)... ... November 24, 2015 , ... Preparing for the LDT Regulation:, ... p.m. EST, , FDA has long asserted that design and manufacture ... performing the tests and do not meet the device regulations. , Come up short ...
(Date:11/24/2015)... Richey, FL (PRWEB) , ... November 24, 2015 , ... ... deems a growing epidemic as deaths from prescription opioids in the United States grew ... and cocaine. In 2013 alone, opioids were involved in 37 percent of all fatal ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 ... global pharmaceutical company, and Rugen Therapeutics, a start-up ... treatments for unmet CNS disorders and funded by ... that they have entered into an exclusive collaboration ... therapies for Autism Spectrum Disorders (ASD) and Obsessive ...
(Date:11/25/2015)... Nov. 25, 2015  Mindray Medical ... MR ), a leading developer, ... worldwide, today announced that it will ... of shareholders at the Company,s Hong Kong office ... Prince Edward West Road, Mongkok KL, Hong ...
(Date:11/25/2015)... November 25, 2015 ... addition of the  "Global Drug Device ... to their offering.  --> ... of the  "Global Drug Device Combination ... their offering.  --> Research ...
Breaking Medicine Technology: